Tech Company Financing Transactions
Lexicon Pharmaceuticals Funding Round
On 5/4/2026, Lexicon Pharmaceuticals raised $100 million in financing from Hercules Capital.
Transaction Overview
Company Name
Announced On
5/4/2026
Transaction Type
Debt
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2445 Technology Forest Blvd 11th floor
The Woodlands, TX 77381
USA
The Woodlands, TX 77381
USA
Phone
Website
Email Address
Overview
Lexicon Pharmaceuticals is a biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Exton
Chief Financial Officer
Scott Coiante
Chief Medical Officer
Craig Granowitz
Vice President
Suma Gopinathan
VP - Client Services
Rachel Martens
VP - General Counsel
Brian Crum
VP - Human Resources
Wendy McDermott
VP - Marketing
Lisa DeFrancesco
Browse more venture capital transactions:
Prev: 5/4/2026: Suno venture capital transaction
Next: 5/4/2026: HealthFab venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs